39 related articles for article (PubMed ID: 19251936)
1. Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc.
Bakiri L; Hasenfuss SC; Guío-Carrión A; Thomsen MK; Hasselblatt P; Wagner EF
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2404188121. PubMed ID: 38657045
[TBL] [Abstract][Full Text] [Related]
2. Role of Fra-2 in cancer.
Rampioni Vinciguerra GL; Capece M; Scafetta G; Rentsch S; Vecchione A; Lovat F; Croce CM
Cell Death Differ; 2024 Feb; 31(2):136-149. PubMed ID: 38104183
[TBL] [Abstract][Full Text] [Related]
3. Fra-1 regulates its target genes via binding to remote enhancers without exerting major control on chromatin architecture in triple negative breast cancers.
Bejjani F; Tolza C; Boulanger M; Downes D; Romero R; Maqbool MA; Zine El Aabidine A; Andrau JC; Lebre S; Brehelin L; Parrinello H; Rohmer M; Kaoma T; Vallar L; Hughes JR; Zibara K; Lecellier CH; Piechaczyk M; Jariel-Encontre I
Nucleic Acids Res; 2021 Mar; 49(5):2488-2508. PubMed ID: 33533919
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of FRA1 (
Al-Khayyat W; Pirkkanen J; Dougherty J; Laframboise T; Dickinson N; Khaper N; Lees SJ; Mendonca MS; Boreham DR; Tai TC; Thome C; Tharmalingam S
Cells; 2023 Sep; 12(19):. PubMed ID: 37830558
[TBL] [Abstract][Full Text] [Related]
5. GRaNIE and GRaNPA: inference and evaluation of enhancer-mediated gene regulatory networks.
Kamal A; Arnold C; Claringbould A; Moussa R; Servaas NH; Kholmatov M; Daga N; Nogina D; Mueller-Dott S; Reyes-Palomares A; Palla G; Sigalova O; Bunina D; Pabst C; Zaugg JB
Mol Syst Biol; 2023 Jun; 19(6):e11627. PubMed ID: 37073532
[TBL] [Abstract][Full Text] [Related]
6. The Fra-1: Novel role in regulating extensive immune cell states and affecting inflammatory diseases.
He YY; Zhou HF; Chen L; Wang YT; Xie WL; Xu ZZ; Xiong Y; Feng YQ; Liu GY; Li X; Liu J; Wu QP
Front Immunol; 2022; 13():954744. PubMed ID: 36032067
[TBL] [Abstract][Full Text] [Related]
7. The Transcription Factor FRA-1/AP-1 Controls Lipocalin-2 Expression and Inflammation in Sepsis Model.
Cao S; Schnelzer A; Hannemann N; Schett G; Soulat D; Bozec A
Front Immunol; 2021; 12():701675. PubMed ID: 34712224
[TBL] [Abstract][Full Text] [Related]
8. Interactome Networks of FOSL1 and FOSL2 in Human Th17 Cells.
Shetty A; Bhosale SD; Tripathi SK; Buchacher T; Biradar R; Rasool O; Moulder R; Galande S; Lahesmaa R
ACS Omega; 2021 Sep; 6(38):24834-24847. PubMed ID: 34604665
[TBL] [Abstract][Full Text] [Related]
9. Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300.
Williams LM; McCann FE; Cabrita MA; Layton T; Cribbs A; Knezevic B; Fang H; Knight J; Zhang M; Fischer R; Bonham S; Steenbeek LM; Yang N; Sood M; Bainbridge C; Warwick D; Harry L; Davidson D; Xie W; Sundstrӧm M; Feldmann M; Nanchahal J
Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20753-20763. PubMed ID: 32759223
[TBL] [Abstract][Full Text] [Related]
10. Visualization of Fra-1/AP-1 activation during LPS-induced inflammatory lung injury using fluorescence optical imaging.
Rajasekaran S; Tamatam CR; Potteti HR; Raman V; Lee JW; Matthay MA; Mehta D; Reddy NM; Reddy SP
Am J Physiol Lung Cell Mol Physiol; 2015 Aug; 309(4):L414-24. PubMed ID: 26071555
[TBL] [Abstract][Full Text] [Related]
11. A NF-κB-dependent dual promoter-enhancer initiates the lipopolysaccharide-mediated transcriptional activation of the chicken lysozyme in macrophages.
Witham J; Ouboussad L; Lefevre PF
PLoS One; 2013; 8(3):e59389. PubMed ID: 23533622
[TBL] [Abstract][Full Text] [Related]
12. Genetic disruption of Fra-1 decreases susceptibility to endotoxin-induced acute lung injury and mortality in mice.
Vaz M; Reddy NM; Rajasekaran S; Reddy SP
Am J Respir Cell Mol Biol; 2012 Jan; 46(1):55-62. PubMed ID: 21816965
[TBL] [Abstract][Full Text] [Related]
13. Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation.
Wu GJ; Chen TL; Ueng YF; Chen RM
Toxicol Appl Pharmacol; 2008 Apr; 228(1):105-13. PubMed ID: 18191973
[TBL] [Abstract][Full Text] [Related]
14. Expression and distribution of AP-1 transcription factors in the porcine ovary.
Rusovici R; LaVoie HA
Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371
[TBL] [Abstract][Full Text] [Related]
15. Dietary energy restriction, in part through glucocorticoid hormones, mediates the impact of 12-O-tetradecanoylphorbol-13-acetate on jun D and fra-1 in Sencar mouse epidermis.
Przybyszewski J; Wang W; Au A; Perry C; Guetzko M; Koehler K; Birt DF
Mol Carcinog; 2010 Jun; 49(6):592-602. PubMed ID: 20232358
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-independent- versus ubiquitin-dependent proteasomal degradation of the c-Fos and Fra-1 transcription factors: is there a unique answer?
Basbous J; Jariel-Encontre I; Gomard T; Bossis G; Piechaczyk M
Biochimie; 2008 Feb; 90(2):296-305. PubMed ID: 17825471
[TBL] [Abstract][Full Text] [Related]
17. Fra-1 a target for cancer prevention or intervention.
Young MR; Colburn NH
Gene; 2006 Sep; 379():1-11. PubMed ID: 16784822
[TBL] [Abstract][Full Text] [Related]
18. Fra-1 negatively regulates lipopolysaccharide-mediated inflammatory responses.
Morishita H; Saito F; Kayama H; Atarashi K; Kuwata H; Yamamoto M; Takeda K
Int Immunol; 2009 Apr; 21(4):457-65. PubMed ID: 19251936
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
